Search
Search Results
-
-
Hydroxychloroquin – nicht immer ein harmloses Medikament für den Off-label-Gebrauch in der Dermatologie
Hydroxychloroquine is used for treatment of inflammatory diseases. It is considered to have few adverse effects. We report on a woman who developed...
-
-
Management der ANCA-assoziierten Vaskulitiden
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an autoimmune-mediated inflammation of small and medium-sized vessels that...
-
Einfluss von Grunderkrankung und Immunsuppression auf die Immunkompetenz bei entzündlich rheumatischen Erkrankungen
Patients with inflammatory rheumatic diseases have a higher risk of infections in comparison to the general population. For this patient group, in...
-
-
Medikamenteninduzierte Osteopathien in der Rheumatologie
Osteopathy in rheumatology can either be primary a condition as a consequence of inflammatory rheumatic diseases but can also be drug induced. The...
-
-
Diagnose und Therapie der Granulomatose mit Polyangiitis und mikroskopische Polyangiitis – 2023: Konsens-Empfehlungen der Österreichischen Gesellschaften für Nephrologie (ÖGN) & Rheumatologie (ÖGR)
ANCA-associated vasculitides (AAV) are rare, complex systemic diseases that are often difficult to diagnose, because of unspecific clinical symptoms...
-
-
Chirurgische Therapie des Pseudomyxoma-peritonei-Syndroms – zytoreduktive Chirurgie und hypertherme intraperitoneale Chemotherapie
BackgroundPseudomyxoma peritonei syndrome (PMP) is an orphan disease. Surgery is the fundament of treatment.
MethodShort review summarizing the...
-
Wie sicher ist die Gentherapie?
BackgroundDuchenne muscular dystrophy (DMD) is a severe monogenic hereditary disease with early manifestation and a progressive course. Treatment...
-
-
-
Botulinumtoxin A bei idiopathischer Blasenüberaktivität (iOAB) der Frau
Following a description of the historic evolution of botulinum toxin A detrusor injections for neurogenic and nonneurogenic bladder overactivity,...